Experimental COVID-19 vaccine safe, generated immune response
On Jul. 14, 2020, an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus…
CDC called on Americans to wear masks to prevent COVID-19 spread
On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…
HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2
On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the…
Moderna announced publication in The New England Journal of Medicine of interim results from phase 1 study of its mRNA vaccine against COVID-19
On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…
Pascal Biosciences discovered a cannabinoid that combats Coronavirus
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
Engineered llama antibodies neutralised Covid-19 virus
On Jul. 13, 2020, a team of researchers from Oxford University, the Rosalind Franklin Institute, Diamond Light Source…
Junshi Biosciences and Lonza announced partnership to produce a neutralizing antibody tackling COVID-19
On Jul. 13, 2020, Lonza and Junshi Biosciences announced that the first healthy volunteer had been dosed in…
Innovation Pharma’s clinical trial testing of brilacidin against COVID-19 targeted to commence in 2020 fourth quarter
On Jul. 13, 2020, Innovation Pharma announced that, in parallel to previously reported manufacturing efforts, the Company had…
Pfizer and BioNTech granted FDA Fast Track Designation for two investigational mRNA-based vaccine candidates against SARS-CoV-2
On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesﾒ four investigational vaccine candidates from…
Meridian Bioscience launched high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for development of rapid COVID-19 antigen assays
On Jul. 13, 2020, Meridian Bioscience announced it had launched a high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for the…
Spanish National Center for Biotechnology uses Atos supercomputing expertise to find out how Covid-19 virus initiates infection
On Jul. 9, 2020, Atos announced that the Biocomputing Unit at the Spanish National Center for Biotechnology (CNB),…
ViralClear partnered with Albany Molecular on manufacture of merimepodib API development for potential treatment of COVID-19
On Jul. 9, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced that it is partnering with Albany…
Kaiser Permanente Washington announced COVID-19 vaccine trial registry opened for volunteers
On Jul. 8, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that it had created a registry…
Kleo Pharmaceuticals announced $5 million grant to advance development of COVID-19 hyperimmune globulin mimic as therapeutic for infected patients
On Jul. 8, 2020, Kleo Pharmaceuticals announced that it had received a $5 million grant from the Bill…
NanoViricides reported safety and tolerability of anti-Coronavirus drug candidates observed in animal model
On Jul. 8, 2020, NanoViricides announced that excellent safety and tolerability of the drug candidates it is developing…
The FDA reported false positive results with BD SARS-CoV-2 reagents for the BD Max System
On Jul. 7, 2020, the FDA alerted clinical laboratory staff and health care providers of an increased risk…
The FDA reported false positive results with BD SARS-CoV-2 reagents for the BD Max System
On Jul. 7, 2020, the FDA alerted clinical laboratory staff and health care providers of an increased risk…
Cerus reported successful inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma
On Jul. 7, 2020, Cerus announced study results that demonstrated the INTERCEPT Blood System inactivates SARS-CoV-2, the causative…
In vitro testing of Innovation Pharmasﾒ Brilacidin for COVID-19 showed consistent anti-SARS-CoV-2 efficacy
On Jul. 7, 2020, Innovation Pharma reported the latest developments related to research into Brilacidin as a potential…
European Investment Bank and EC provided CureVac with $75 million financing for vaccine development and expansion of manufacturing
On Jul. 6, 2020, the European Investment Bank (EIB) and CureVac announced they had entered into a $75…
Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnsonﾒs COVID-19 vaccine candidate
On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…
Anixa Biosciences and OntoChem announced completion of initial screening program and identification of additional Covid-19 compounds
On Jul. 6, 2020, Anixa Biosciences announced that it and partner OntoChem had completed the initial in silico…
BD launched portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes, expanding access to COVID-19 testing
On Jul. 6, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
EC granted conditional Marketing Authorization for Gileadﾒs Vekluryﾮ (remdesivir) for treatment of COVID-19
On Jul. 3, 2020, Gilead Sciences announced the European Commission had granted conditional marketing authorization for Vekluryﾮ (remdesivir)…
From Wuhan to San Diego – How a mutation on the novel coronavirus dominated the globe
On Jul. 2, 2020, scientists from Duke University, Los Alamos National Laboratory and La Jolla Institute for Immunology…
Maxim Biomedical rapid antigen COVID-19 test to deliver results in less than 15 minutes
On Jul. 2, 2020, Maxim Biomedical announced plans to produce and market as many as 3 million Maxim…
Ceres’ published data demonstrated a rapid and versatile method for improving detection of SARS-CoV-2
On Jul. 2, 2020, Ceres Nanosciences and its collaborators at George Mason University announced they had have developed…
NIH ACTIV vaccine working group weighed role of human challenge studies for SARS-CoV-2 vaccine development
On Jul. 1, 2020, in a Perspective for the New England Journal of Medicine, members of the NIHﾒs…
T2 Biosystems announces US launch of COVID-19 diagnostic test
On Jul. 1, 2020, T2 Biosystems announced completion of validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2…
Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…